Results
23
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
23 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ADOC | €6.42 | 3.0% | 23.0% | €96.6m | €6.30 | PS16x | E63.0% | n/a | Pharmaceuticals & Biotech | ||
ALOKW | €13.58 | -28.9% | -47.4% | €112.2m | €20.75 | PE14.8x | E36.0% | n/a | Capital Goods | ||
VU | €137.50 | -1.2% | 11.6% | €2.2b | €195.20 | PE27.4x | E23.3% | 0.2% | Tech | ||
OSE | €7.61 | 15.8% | 134.2% | €165.5m | €11.43 | PS74.3x | E5.9% | n/a | Pharmaceuticals & Biotech | ||
FDE | €28.50 | -2.4% | -38.0% | €149.1m | €60.33 | PE19x | E31.9% | n/a | Energy | ||
ALMUN | €0.45 | -5.4% | -82.1% | €4.0m | €1.30 | PB0.3x | E149.2% | n/a | Tech | ||
ALICA | €10.70 | 0% | -22.5% | €86.5m | €16.00 | PE15.8x | E35.1% | 1.9% | Tech | ||
ALCUR | €6.28 | -7.4% | 153.2% | €36.2m | €8.48 | PE20.1x | E27.5% | n/a | Capital Goods | ||
MEDCL | €15.56 | 1.2% | 147.0% | €452.2m | €20.70 | PS37.9x | E69.6% | n/a | Pharmaceuticals & Biotech | ||
ALSMA | €4.32 | 1.2% | 71.4% | €22.5m | €5.80 | PE21.3x | E35.2% | n/a | Healthcare | ||
ALSTI | €16.00 | -14.7% | n/a | €81.4m | €16.50 | PE40.7x | E28.5% | 1.2% | Capital Goods | ||
ALLIX | €8.08 | 1.0% | -24.1% | €52.6m | €13.50 | PS1.6x | E102.1% | n/a | Software | ||
ALECP | €0.34 | -2.6% | -34.8% | €41.7m | n/a | PE46.4x | E86.8% | 0% | Media | ||
ALVGO | €3.63 | 12.7% | -10.6% | €22.1m | €4.40 | PS1.8x | E77.2% | n/a | Software | ||
ALHOP | €22.70 | -1.3% | 30.5% | €65.2m | €30.05 | PE14.3x | E21.6% | 2.9% | Media | ||
ALCIS | €8.48 | -1.9% | -18.1% | €66.0m | €12.10 | PE20.7x | E56.5% | 1.9% | Commercial Services | ||
ATEME | €3.85 | -3.8% | -59.6% | €44.2m | €8.00 | PB1.2x | E96.4% | n/a | Tech | ||
OVH | €5.85 | 5.1% | -42.9% | €1.1b | €8.61 | PS1.2x | E101.1% | n/a | Software | ||
LSS | €26.80 | -5.1% | -6.5% | €1.0b | €34.58 | PE31.8x | E32.6% | 1.3% | Software | ||
CLA | €1.73 | -3.0% | 9.6% | €98.4m | €4.75 | PE-19.7x | E90.6% | n/a | Software | ||
S30 | €1.59 | -4.6% | -47.8% | €170.2m | €2.35 | PB1.5x | E103.3% | n/a | Software | ||
ALPAT | €15.90 | 10.4% | 27.2% | €17.5m | €11.50 | n/a | E92.7% | n/a | Pharmaceuticals & Biotech | ||
EXN | €23.30 | 0.9% | 22.2% | €2.1b | €24.61 | PE51.3x | E32.4% | 0% | Software |